Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,282 public trials 1,199 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

NCT02838836

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +38 more
Locations: Ellis Fischel Cancer Center, University of Missouri Columbia, Missouri, United States

View Trial Details

Recruiting

A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive

NCT06930794

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details

Recruiting

Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

NCT07561567

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Recruiting

Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer

NCT07563205

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: CH du Pays d Aix - Service des Maladies Respiratoires Aix-en-Provence, France

APHP Hôpital Avicennes Bobigny, France

Hôpital Louis Pradel Bron, France

Pneumologie Centre François Baclesse Caen, France

View all 16 locations

View Trial Details

Recruiting

This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

NCT07249879

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Beijing Gobroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

NCT05398094

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Hospital General Universitario de Alicante Alicante, Spain

ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Hospital Universitari Quiron Dexeus Barcelona, Spain

Hospital Universitari Vall d' Hebron Barcelona, Spain

View all 20 locations

View Trial Details

Recruiting

Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC

NCT07309952

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

NCT07279402

Conditions: Atezolizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: Adana City Hospital Adana, Turkey (Türkiye)

Afyonkarahisar Health Sciences University Hospital Afyonkarahisar, Turkey (Türkiye)

Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)

Memorial Ankara Hospital Ankara, Turkey (Türkiye)

View all 25 locations

View Trial Details

Recruiting

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

NCT06247826

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Oncologie Polyclinique Bordeaux Nord Aquitaine Bordeaux, France

Centre Hospitalier du Morvan Brest, France

Pneumologie Centre Hospitalier Intercommunal de Créteil Créteil, France

Oncologie, CLCC Dijon Dijon, France

View all 18 locations

View Trial Details

Recruiting

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

NCT05903092

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +11 more
Locations: Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States

University of Virginia Health System Charlottesville, Virginia, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions